Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

clinical trial

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02376296

P17countryUnited States of AmericaQ30
P582end time2017-11-01
P921main subjectmetastatic prostate carcinomaQ55779807
Castrate-resistant prostate cancer: the future of antiandrogensQ56016972
P2899minimum age18
P1132number of participants80
P580start time2015-02-01
P8363study typeobservational studyQ818574
P1476titleObservational Study of Metastatic Prostate Cancer Subjects Receiving Docetaxel Therapy for Evaluation of Docetaxel Plasma Levels Using the MyDocetaxel Assay

Search more.